No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 1,349,522 | 1,211,725 | 1,612,688 | 1,879,547 | 1,749,743 | 1,809,164 | 1,668,754 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 33,970 | 57,873 | 109,990 | 82,936 | 49,999 | 32,242 | 34,378 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Mitsui Chemicals, Inc. is a diversified chemical enterprise operating across key sectors including mobility, healthcare, food and packaging, and basic materials. Within its Mobility division, it develops and supplies elastomers, various performance compounds, and functional polymers primarily for automotive and industrial applications, alongside offering related development services. The Health Care segment furnishes materials for optical products, nonwovens, dental procedures, and general personal care. Its Food and Packaging unit delivers specialized coating and engineering materials, high-performance films and sheets, and agrochemical solutions. The Basic Materials division is a significant producer of foundational chemicals such as ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid (PTA), PET, and polyurethane intermediates, in addition to other industrial chemicals. Beyond these core areas, Mitsui Chemicals' extensive product portfolio extends to civil engineering and construction materials, cosmetic ingredients, various adhesives (for wood and paper), foliar activators, a broad range of polyolefin and urethane resins and films, injection molding equipment, phosphoric acid, and fertilizers. Further offerings include spunbonded nonwoven fabrics, synthetic fibers, monomers for optical lenses, and a variety of fine and inorganic chemicals. The company also provides comprehensive technical services, encompassing performance analysis, physical property measurements, and safety evaluations for chemicals. Furthermore, its ancillary operations include personnel placement, temporary staffing, insurance and travel services, consignment business, and the sale of electronics and information technology materials. Mitsui Chemicals maintains a robust global sales network, serving markets in Japan, China, the wider Asian region, the Americas, and Europe. The company was established in Tokyo, Japan, in 1892, where it continues to maintain its corporate headquarters.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Mitsui Chemicals, Inc. (4183.T)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Mitsui Chemicals, Inc. is a diversified chemical enterprise operating across key sectors including mobility, healthcare, food and packaging, and basic materials. Within its Mobility division, it develops and supplies elastomers, various performance compounds, and functional polymers primarily for automotive and industrial applications, alongside offering related development services. The Health Care segment furnishes materials for optical products, nonwovens, dental procedures, and general personal care. Its Food and Packaging unit delivers specialized coating and engineering materials, high-performance films and sheets, and agrochemical solutions. The Basic Materials division is a significant producer of foundational chemicals such as ethylene, propylene, polyethylene, polypropylene, catalysts, phenols, purified terephthalic acid (PTA), PET, and polyurethane intermediates, in addition to other industrial chemicals. Beyond these core areas, Mitsui Chemicals' extensive product portfolio extends to civil engineering and construction materials, cosmetic ingredients, various adhesives (for wood and paper), foliar activators, a broad range of polyolefin and urethane resins and films, injection molding equipment, phosphoric acid, and fertilizers. Further offerings include spunbonded nonwoven fabrics, synthetic fibers, monomers for optical lenses, and a variety of fine and inorganic chemicals. The company also provides comprehensive technical services, encompassing performance analysis, physical property measurements, and safety evaluations for chemicals. Furthermore, its ancillary operations include personnel placement, temporary staffing, insurance and travel services, consignment business, and the sale of electronics and information technology materials. Mitsui Chemicals maintains a robust global sales network, serving markets in Japan, China, the wider Asian region, the Americas, and Europe. The company was established in Tokyo, Japan, in 1892, where it continues to maintain its corporate headquarters.
